An integrated microcatheter-based dual-analyte sensor system for simultaneous, real-time measurement of propofol and fentanyl

According to the American Society of Anesthesiologists Closed Claims Database, one of three drug-related errors is the result administrating an incorrect dose. Directly measuring drug concentration removes the uncertainty in the dose-concentration relationship and addresses inter- and intra-subject...

Full description

Saved in:
Bibliographic Details
Published inTalanta (Oxford) Vol. 218; p. 121205
Main Authors Moonla, Chochanon, Goud, K. Yugender, Teymourian, Hazhir, Tangkuaram, Tanin, Ingrande, Jerry, Suresh, Preetham, Wang, Joseph
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.10.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:According to the American Society of Anesthesiologists Closed Claims Database, one of three drug-related errors is the result administrating an incorrect dose. Directly measuring drug concentration removes the uncertainty in the dose-concentration relationship and addresses inter- and intra-subject variabilities that affect the pharmacokinetics of anesthetics. Here we describe a dual-analyte microcatheter-based electrochemical sensor capable of simultaneous real-time continuous monitoring of fentanyl (FTN) and propofol (PPF) drugs simultaneously in the operating rooms. Such a dual PPF/FTN catheter sensor relies on embedding two different modified carbon paste (CP)-packed working electrodes along with Ag/AgCl microwire reference electrodes within a mm-wide Teflon tube, and uses a square wave voltammetric (SWV) technique. The composition of each working electrode was judiciously tailored to cover the concentration range of interest for each analyte. A polyvinyl chloride (PVC) organic polymer coating on the surface of CP electrode enabled selective and sensitive PPF measurements in μM range. The detection of nM FTN levels was achieved through a multilayered nanostructure-based surface modification protocol, including a CNT-incorporated CP transducer modified by a hybrid of electrodeposited Au nanoparticles and electrochemically reduced graphene oxide (erGO) and a PVC outer membrane. The long-term monitoring capability of the dual sensor was demonstrated in a protein-rich artificial plasma medium. The promising antibiofouling behavior of the catheter-based multiplexed sensor was also illustrated in whole blood samples. The new integrated dual-sensor microcatheter platform holds considerable promise towards real-time, in-vivo detection of the anesthetic drugs, propofol and fentanyl, during surgical procedures towards significantly improved safe delivery of anesthetic drugs. [Display omitted] •Integrated microcatheter-based dual-sensing probe for monitoring of anesthetic drugs.•Real-time, continuous simultaneous in-vivo monitoring of Fentanyl and Propofol in whole blood samples.•Detection of drugs in largely different concentrations without cross talk.•Continuous drugs monitoring during surgical operations towards further medical safety control.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0039-9140
1873-3573
1873-3573
DOI:10.1016/j.talanta.2020.121205